Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.48 |
| ▸ | ACACA | Q13085 | 2/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 8/20 | 0.39 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | EP300 | Q09472 | 1/20 | 0.36 |
| ▸ | EBP | Q15125 | 4/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.32 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.32 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL568813 | 0.86 | HSD11B1 (0.50) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL17599781 | 0.85 | HSD11B1 (0.56) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL1878450 | 0.85 | HSD11B1 (0.56) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL16411312 | 0.85 | ACLY (0.61) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL9618055 | 0.84 | CRYAB (0.46) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL29510985 | 0.83 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL12634185 | 0.83 | ACLY (0.67) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL377472 | 0.74 | ACLY (0.38) | ACLYACACAPTPN11HSD11B1HSD11B2 | |
| SCHEMBL8148952 | 0.73 | EBP (0.48) | ACLYACACAPTPN11HSD11B1PTGS1 | |
| SCHEMBL29511134 | 0.72 | ACLY (0.45) | ACLYACACAPTPN11HSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-61118318-A | — | — | None | — | — | JP | disclosed |
| JP-61118323-A | — | — | None | — | — | JP | disclosed |
| EP-4025676-B1 | PRODUCTION OF AN EXTRACT OF PHYTOSTEROLS AND STANOLS FROM TALL OIL PITCH | PINE CHEMICAL HOLDING S A (LU) | 2023-08-02 | — | — | EP | disclosed |
| EP-4025676-A1 | PRODUCTION OF AN EXTRACT OF PHYTOSTEROLS AND STANOLS FROM TALL OIL PITCH | BIO CHEMICAL LUXEMBOURG HOLDING S.A. (LU) | 2022-07-13 | — | — | EP | disclosed |
| WO-2021043845-A1 | PRODUCTION OF AN EXTRACT OF PHYTOSTEROLS AND STANOLS FROM TALL OIL PITCH | BIO CHEMICAL LUXEMBOURG HOLDING S.A. (LU) | 2021-03-11 | — | — | WO | disclosed |
| EP-2656737-B1 | FAT AND/OR OIL COMPOSITION | KAO CORP (JP) | 2019-04-24 | — | — | EP | disclosed |
| EP-1882472-B1 | DRUGS, FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | MORINAGA MILK INDUSTRY CO LTD (JP) | 2018-08-22 | — | — | EP | disclosed |
| EP-1930014-B1 | AGENT FOR AMELIORATION OF INSULIN RESISTANCE | MORINAGA MILK INDUSTRY CO LTD (JP) | 2017-03-01 | — | — | EP | disclosed |
| EP-2749176-B1 | OIL/FAT COMPOSITION | KAO CORP (JP) | 2016-08-10 | — | — | EP | disclosed |
| EP-1795200-B1 | MEDICINE AND FOOD/BEVERAGE FOR AMELIORATING HYPERGLYCEMIA | MORINAGA MILK INDUSTRY CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| CN-101277705-A | Agent for amelioration of insulin resistance | MORINAGA MILK INDUSTRY CO LTD (JP) | 2008-10-01 | — | — | CN | disclosed |
| EP-1930014-A1 | AGENT FOR AMELIORATION OF INSULIN RESISTANCE | Morinaga Milk Industry Co., Ltd. (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1882472-A1 | DRUGS, FOOD OR DRINK FOR IMPROVING PANCREATIC FUNCTIONS | Morinaga Milk Industry Co., Ltd. (JP) | 2008-01-30 | — | — | EP | disclosed |
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-08-23 | — | — | US | disclosed |
| EP-1795200-A1 | MEDICINE AND FOOD/BEVERAGE FOR AMELIORATING HYPERGLYCEMIA | MORINAGA MILK INDUSTRY CO., LTD. (JP) | 2007-06-13 | — | — | EP | disclosed |
| EP-0958370-A1 | TRANSGENIC PLANTS WITH MODIFIED STEROL BIOSYNTHETIC PATHWAYS | MONSANTO COMPANY (US) | 1999-11-24 | — | — | EP | disclosed |
| WO-1998045457-A1 | TRANSGENIC PLANTS WITH MODIFIED STEROL BIOSYNTHETIC PATHWAYS | MONSANTO COMPANY (US) | 1998-10-15 | — | — | WO | disclosed |
| EP-0166542-B1 | TRITERPENYL ESTERS OF ORGANIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND HYPOLIPIDEMIC AGENTS COMPOSED OF THEM | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1990-08-08 | — | — | EP | disclosed |
| JP-S61118323-A | COMPOSITION HAVING IMPROVING ACTION ON SERUM LIPID | POLA CHEM IND INC | 1986-06-05 | — | — | JP | disclosed |
| JP-S61118318-A | COMPOSITION HAVING IMPROVING ACTION ON SERUM LIPID | POLA CHEM IND INC | 1986-06-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070196435-A1 | Drug and food or drink for improving hyperglycemia | GPR119, SLC2A9, GCKR | ACLY 565/4885ACACA 305/4885PTPN11 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.